| Offering Information |
| Expected Date | - |
| Proposed Exchange/Ticker |
Nasdaq: SSRX |
| Security Type |
American Depositary Shares |
| Lead Underwriter |
UBS Investment Bank |
| Days In Registration |
18 |
| Date Filed |
19-Jan-2007 |
| Form Filed | F-1 |
Fundamentals
(Year Ending December 2008) |
| Industry |
Manufacturing |
| Business Description |
3SBio Inc, located in Shenyang, China, biopharmaceutical company engaged in research/development, manufacture and marketing/sales of biopharmaceutical products in China. The Company develops recombinant, or genetically engineered, protein-based products and product candidates designed to address large markets with significant unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious disease. Its principal products are EPIAO, TPIAO, INTEFEN and INLEUSIN. Founded in 1993. |
| Revenue |
- |
| Net Income |
- |
| Shares Outstanding (post-offering) |
150.32M |
| Contact |
- |
| Number of Employees |
- |
|
| Original Filing Information |
| US |
| Shares Filed |
7.7M |
| Secondary Shares Filed | 0.51M |
| · As a Percent |
6.7 |
| Primary Shares Filed |
7.19M |
| · As a Percent |
93.3 |
| Overallotment Shares Filed |
1155.0K |
| File Amount |
$100.1M |
| File Price Range |
$14.00 - $12.00 |
| File Mid Price |
$13.00 |
Current Filing Information
(Amended 31-Jan-2007) |
|
US |
|
Shares Filed |
- |
| Secondary Shares Filed |
- |
| · As a Percent |
- |
| Primary Shares Filed |
- |
| · As a Percent |
- |
| Overallotment Shares Filed |
- |
| File Amount |
|
| · % Change from Original |
-100.0 |
| File Price Range |
- - - |
| File Mid Price |
- |
|
